. The first derivative of the pressure tracing (dp/dt) was monitored on line bv . means of an active R-C circuit differentiator with a time constant of 1 msec. The perfusion pressure, balloon pressure, and dp/dt were recorded simultaneously on a direct- response of each heart was obtained at some time during each run by either Ca++ or norepinephrine.
The results of the run were then expressed as a percent of this maximum response, and thus each heart served as its own control. Papillary muscle results were expressed as percent change from control.
Group means were compared with the Student t test, and the statistical significance of the differences was expressed as a P value.
RESULTS
Langendorf Isolated-Heart Perfusion A total of 19 cats (13 normal and 6 denervated) was used for this part of the study. In both normal and chronically denervated hearts, angiotensin always elicited a positive inotropic effect in doses from lo-i0 to lop6 g/ml (Fig. 1) . This positive inotropic effect was dose related, and was characterized by an increase in the maximum dp/dt, but not in a shortened time to peak pressure development.
As can be seen from Fig. 2 , angiotensin also changed the pattern of relaxation.
Specifically, the velocity of relaxation (the negative phase of the dp/dt tracing) was increased.
The total contraction time from the onset of tension development to return to base line was not altered by angiotensin.
Since the base-line parameters of isovolumic pressure and
Response of isolated perfused heart to angiotensin 10-r" g/ml at a faster recording speed. Upper half: left ventricular isovolumic pressure. Lower half: dp/dt. Left panels: control recordings.
Right panels: recordings after angiotensin. anpel: on-line recording of first derivative of pressure tracing dp/dt. percent of maximum response of left ventricular isovolumic pressure on the left, and of the dp/dt on the right. Abscissa: dose of angiotensin in g/ml.
Action Potentials Table 1 summarizes the electrophysiology data obtained. As can be seen resting potential and total voltage were unchanged following any of the doses tested. The 50 % repolarization time was lengthened only at the highest dose given, and is consistent with the major finding.Within the dose ranges tested, angiotensin produced a change in the configuration of phase 2, the plateau phase, in action potentials of both normal (n = 5) and denervated (n = 4) papillary muscles (Figs. 7 and 8) . This occurred at the same time as the positive inotropic effect was taking place. This change can best be described as an exaggeration or a "peaking" of the plateau phase. This peaking was most pronounced at the highest dose, and, therefore, accounts for the slight prolongation of the 50 % repolarization time. It should be emphasized that, although the peaking is present at lower dose ranges of angiotensin, it is not reflected in the measured parameters in Table 1 . recordings after angiotensin. dp/dt as well as the response to angiotensin did not differ either quantitatively or qualitatively between normal and denervated hearts, the values for the normal and denervated hearts were combined in the results. r Figure 3 summarizes the results of studies in all 18 hearts in the form of dose-response curves plotting the dose of angiotensin versus the effect on both the left ventricular pressure and dp/dt.
Myocardial Norepinephrine Stores

Papillary Muscles
Tension development. A total of 20 papillary muscles from 14 cats was used in this phase of the study. Muscles from 12 normal hearts and 8 denervated hearts had the same range of base-line tension development and dT/dt. As in the whole-heart preparations, angiotensin elicited a positive inotropic effect in doses from lo-lo to lo+ g/ml (Figs. 4 and 5). This effect was again dose related, and characterized by an increase in maximum dT/dt, but not a shortened time to peak tension development.
The speed of relaxation was increased, but the total contraction time was not altered. The dose-response curves seen in Fig. 6 summarize all the data obtained from the 20 papillary muscles.
These effects were not blocked by phentolamine (lo+ M) (two experiments), propranolol (lo+ M) (two experiments), or by atropine (5 X 10d5 M) (two experiments). In addition, lidocaine ( 10S6 M) (used in an experiment as a model of a local anesthetic)
did not block angiotensin's effects. Each of these doses was one that had been found effective DISCUSSION These results indicate that angiotensin II within a wide dose range is capable of eliciting a direct positive inotropic effect on mammalian ventricular myocardium which is independent of intact adrenergic ganglia, nerves, or endogenous catecholamine stores. The dose-response curves for two quite different types of experimental preparations showed a high degree of correlation in magnitude of response as well as dose ranges. The data pertaining to electrophysiology serve to strengthen this argument, for it would seen unlikely that a substance which has no direct effect on the myocardial cell would produce a change in the action potential which is totally coincident in time with the positive inotropic effect, and which is seen in the normal and catecholamine-depleted hearts alike. In addition, since phentolamine, propranolol, and atropine failed to modify the observed responses, it is unlikely that they were mediated through components of the autonomic nervous system. FIG . 5 . Response of a denervated papillary muscle to angiotensin lo-' g/ml.
In the upper half; tension-is-recorded. 1 . E$ect of angiotensin on transmembrane action potential at 25 C shortened time to peak tension. This study confirms this and also demonstrates that the same pattern of response is true in a whole-heart preparation. In addition, it was observed that the rate of relaxation increases, as well as the rate of contraction, both in the papillary muscle and in the whole heart. Koch-Weser had also observed that cooling did not alter the absolute inotropic effect, and in the present studies both the papillary muscle at 25 C and the whole heart at 34 C did in fact exhibit responses of comparable magnitude to angiotensin. The conclusion by some authors that the cardiac effects of angiotensin are in some way indirect has drawn apparent support from the fact that angiotensin stimulates the adrenal medulla, causing a release of catecholamines (15), and that it also increases levels of plasma and myocardial catecholamines following an intravenous infusion in intact dogs (14). M ore recently, Farr and Grupp (6) by an increased rate of tension development, but not by a Received for publication 3 June 1970.
